{
    "2019-03-20": [
        [
            {
                "time": "2023-10-15",
                "original_text": "Major biotech landlord plants flag in East Bay with acquisition of Novartis site",
                "features": {
                    "keywords": [
                        "biotech",
                        "acquisition",
                        "Novartis",
                        "East Bay"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "real estate"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-10-15",
                "original_text": "Conatus (CNAT) Focuses on Developing NASH Candidate Emricasan",
                "features": {
                    "keywords": [
                        "Conatus",
                        "NASH",
                        "Emricasan",
                        "development"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-10-15",
                "original_text": "Jazz Pharmaceuticals' Sleep Drug NDA Awaits FDA Decision",
                "features": {
                    "keywords": [
                        "Jazz Pharmaceuticals",
                        "Sleep Drug",
                        "NDA",
                        "FDA",
                        "Decision"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}